Sai Life Sciences inks pact to acquire land along with certain building structures in Shamirpet

27 Jan 2025 Evaluate

Sai Life Sciences has entered into a long-term lease agreement for acquiring an area of 1.21 acres of land along with certain building structures in Shamirpet, Hyderabad at an upfront investment of around Rs 15 crore. The company plans to create R&D facility on the said leased land which will augment the existing Unit II Hyderabad Facility. The said investment will be funded from internal accruals. The proposed facility is expected to be partially operational in Q4 of financial year ending March 2026.

Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.


Sai Life Sciences Share Price

875.50 8.70 (1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×